Ignite Creation Date:
2025-12-25 @ 4:29 AM
Ignite Modification Date:
2026-03-03 @ 12:34 AM
Study NCT ID:
NCT03002818
Status:
COMPLETED
Last Update Posted:
2019-10-23
First Post:
2016-12-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-25
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-15
First Submit QC Date:
None
Study First Post Date:
2016-12-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-09-30
Results First Submit QC Date:
None
Results First Post Date:
2019-10-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-30
Last Update Post Date:
2019-10-23
Last Update Post Date Type:
ACTUAL